Christian Lacks Lino Cardenas, Ph.D., Pharm.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth, Vascular | 5 | 2022 | 1504 | 1.450 |
Why?
|
| Aortic Aneurysm, Thoracic | 6 | 2022 | 686 | 1.220 |
Why?
|
| Alzheimer Disease | 4 | 2022 | 8037 | 0.760 |
Why?
|
| Myocytes, Smooth Muscle | 8 | 2023 | 687 | 0.750 |
Why?
|
| Transforming Growth Factor beta | 4 | 2022 | 2007 | 0.740 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2011 | 419 | 0.740 |
Why?
|
| Apolipoprotein E4 | 1 | 2022 | 668 | 0.620 |
Why?
|
| MicroRNAs | 7 | 2023 | 3752 | 0.620 |
Why?
|
| Virus Internalization | 1 | 2021 | 501 | 0.610 |
Why?
|
| Histone Deacetylases | 2 | 2019 | 728 | 0.570 |
Why?
|
| Indazoles | 1 | 2018 | 289 | 0.560 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 4 | 2019 | 451 | 0.530 |
Why?
|
| Estrogens | 1 | 2021 | 1566 | 0.490 |
Why?
|
| Drug Discovery | 1 | 2022 | 1058 | 0.460 |
Why?
|
| Pyridones | 1 | 2018 | 712 | 0.450 |
Why?
|
| Caveolin 1 | 2 | 2019 | 263 | 0.430 |
Why?
|
| DNA Helicases | 1 | 2018 | 859 | 0.430 |
Why?
|
| Capsid | 1 | 2023 | 436 | 0.380 |
Why?
|
| Repressor Proteins | 2 | 2019 | 3023 | 0.360 |
Why?
|
| Acyltransferases | 1 | 2010 | 294 | 0.330 |
Why?
|
| Dependovirus | 1 | 2023 | 706 | 0.320 |
Why?
|
| Marfan Syndrome | 2 | 2021 | 240 | 0.300 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 3 | 2011 | 335 | 0.290 |
Why?
|
| Aortic Aneurysm | 2 | 2022 | 643 | 0.290 |
Why?
|
| Pericytes | 2 | 2023 | 292 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2023 | 15519 | 0.250 |
Why?
|
| Amyloid beta-Peptides | 3 | 2022 | 3587 | 0.250 |
Why?
|
| Muscle Contraction | 2 | 2019 | 1240 | 0.230 |
Why?
|
| Polymorphism, Genetic | 2 | 2010 | 4328 | 0.220 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5853 | 0.220 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2022 | 40 | 0.220 |
Why?
|
| Fibroblasts | 4 | 2019 | 4161 | 0.210 |
Why?
|
| Computational Biology | 2 | 2011 | 3521 | 0.210 |
Why?
|
| Apolipoprotein E3 | 1 | 2022 | 97 | 0.210 |
Why?
|
| Atherosclerosis | 3 | 2023 | 3445 | 0.210 |
Why?
|
| Tunicamycin | 1 | 2021 | 112 | 0.200 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2022 | 152 | 0.200 |
Why?
|
| Mice | 16 | 2022 | 81183 | 0.200 |
Why?
|
| France | 3 | 2011 | 517 | 0.200 |
Why?
|
| Gene Frequency | 4 | 2011 | 3588 | 0.190 |
Why?
|
| Patents as Topic | 1 | 2022 | 103 | 0.190 |
Why?
|
| Plants | 1 | 2022 | 316 | 0.180 |
Why?
|
| Calcium-Binding Proteins | 2 | 2023 | 1081 | 0.180 |
Why?
|
| Connective Tissue Diseases | 1 | 2022 | 264 | 0.180 |
Why?
|
| Enoxaparin | 1 | 2022 | 377 | 0.170 |
Why?
|
| Coronary Artery Disease | 3 | 2023 | 6487 | 0.170 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 18029 | 0.170 |
Why?
|
| Transcription Factors | 2 | 2023 | 12208 | 0.170 |
Why?
|
| Peru | 1 | 2022 | 881 | 0.170 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 413 | 0.170 |
Why?
|
| Muscle, Smooth | 1 | 2023 | 934 | 0.160 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2022 | 451 | 0.160 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2022 | 314 | 0.160 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 3505 | 0.160 |
Why?
|
| Craniosynostoses | 1 | 2022 | 401 | 0.160 |
Why?
|
| Glycosylation | 1 | 2021 | 1126 | 0.160 |
Why?
|
| Lung | 4 | 2013 | 9856 | 0.160 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 729 | 0.150 |
Why?
|
| Histones | 2 | 2018 | 2599 | 0.150 |
Why?
|
| Hypertension | 2 | 2023 | 8480 | 0.150 |
Why?
|
| Actomyosin | 1 | 2018 | 111 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2021 | 849 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 6171 | 0.150 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2022 | 2557 | 0.150 |
Why?
|
| Models, Molecular | 2 | 2021 | 5456 | 0.150 |
Why?
|
| Aorta | 3 | 2022 | 2061 | 0.150 |
Why?
|
| Biological Transport | 1 | 2021 | 2118 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2019 | 14557 | 0.140 |
Why?
|
| Animals | 16 | 2022 | 168757 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2023 | 19229 | 0.140 |
Why?
|
| Losartan | 1 | 2018 | 299 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 234 | 0.140 |
Why?
|
| Bleomycin | 2 | 2017 | 512 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2011 | 6544 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 838 | 0.130 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 809 | 0.130 |
Why?
|
| Polysaccharides | 1 | 2021 | 1053 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2023 | 10481 | 0.120 |
Why?
|
| DNA Methylation | 2 | 2018 | 4286 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 18111 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 2505 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 21827 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 2022 | 1161 | 0.110 |
Why?
|
| Genotype | 4 | 2011 | 12951 | 0.110 |
Why?
|
| Humans | 29 | 2023 | 744343 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2018 | 4751 | 0.110 |
Why?
|
| Muscle Proteins | 1 | 2018 | 1159 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 1152 | 0.110 |
Why?
|
| tau Proteins | 1 | 2022 | 1868 | 0.100 |
Why?
|
| Myocardial Infarction | 2 | 2023 | 11727 | 0.100 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2023 | 1519 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 1082 | 0.100 |
Why?
|
| Cell Movement | 2 | 2014 | 5217 | 0.100 |
Why?
|
| IMP Dehydrogenase | 1 | 2010 | 34 | 0.100 |
Why?
|
| Biocatalysis | 1 | 2011 | 167 | 0.100 |
Why?
|
| Heart Valve Diseases | 1 | 2018 | 1073 | 0.090 |
Why?
|
| Heparin | 1 | 2018 | 1637 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2023 | 913 | 0.090 |
Why?
|
| Acute Lung Injury | 1 | 2014 | 380 | 0.090 |
Why?
|
| Capsid Proteins | 1 | 2023 | 479 | 0.090 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2010 | 226 | 0.090 |
Why?
|
| Chemokines | 1 | 2014 | 970 | 0.090 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2009 | 61 | 0.090 |
Why?
|
| Base Sequence | 2 | 2011 | 12797 | 0.090 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 1708 | 0.090 |
Why?
|
| Smad Proteins | 2 | 2020 | 162 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 2866 | 0.080 |
Why?
|
| RNA Interference | 1 | 2018 | 2889 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2018 | 2969 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 13815 | 0.080 |
Why?
|
| Aortic Valve | 1 | 2018 | 1922 | 0.080 |
Why?
|
| Mitochondria | 1 | 2021 | 3520 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2020 | 23403 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2010 | 1246 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 2839 | 0.070 |
Why?
|
| Genome-Wide Association Study | 5 | 2023 | 12261 | 0.070 |
Why?
|
| DNA Primers | 1 | 2011 | 2892 | 0.070 |
Why?
|
| Phenotype | 3 | 2019 | 16365 | 0.070 |
Why?
|
| Mesoderm | 1 | 2009 | 686 | 0.070 |
Why?
|
| Chromatin | 1 | 2018 | 2934 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2010 | 2256 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 1213 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 3616 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3647 | 0.060 |
Why?
|
| Mutation | 3 | 2018 | 29786 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2011 | 1783 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3846 | 0.060 |
Why?
|
| Male | 10 | 2022 | 350118 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 17446 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2023 | 3420 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2013 | 4217 | 0.060 |
Why?
|
| Cell Line | 1 | 2018 | 15997 | 0.060 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 1632 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2011 | 1809 | 0.060 |
Why?
|
| RNA, Nuclear | 1 | 2022 | 30 | 0.050 |
Why?
|
| Binding Sites | 1 | 2011 | 6114 | 0.050 |
Why?
|
| Brain | 3 | 2023 | 26385 | 0.050 |
Why?
|
| Fibrillar Collagens | 1 | 2022 | 41 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2564 | 0.050 |
Why?
|
| Actinin | 1 | 2022 | 160 | 0.050 |
Why?
|
| Pandemics | 1 | 2022 | 8388 | 0.050 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2022 | 314 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2022 | 520 | 0.050 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2020 | 22 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 12072 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 4803 | 0.040 |
Why?
|
| Gene Expression | 1 | 2013 | 7799 | 0.040 |
Why?
|
| Alleles | 1 | 2010 | 6933 | 0.040 |
Why?
|
| Cytokines | 1 | 2014 | 7322 | 0.040 |
Why?
|
| Protein Binding | 1 | 2011 | 9386 | 0.040 |
Why?
|
| Siblings | 1 | 2022 | 854 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2017 | 3002 | 0.040 |
Why?
|
| Heart Failure | 1 | 2021 | 10900 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2019 | 222 | 0.040 |
Why?
|
| Female | 9 | 2022 | 380194 | 0.040 |
Why?
|
| Nitrophenols | 1 | 2017 | 172 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 498 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11483 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1654 | 0.030 |
Why?
|
| Aging | 1 | 2014 | 8664 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 2012 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2017 | 905 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2751 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 692 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1889 | 0.030 |
Why?
|
| ROC Curve | 1 | 2019 | 3527 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 2886 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2010 | 141 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2020 | 1972 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2021 | 5007 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1655 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2020 | 2942 | 0.020 |
Why?
|
| Zebrafish | 1 | 2018 | 2994 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 40561 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2513 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2021 | 8554 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2018 | 3479 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13989 | 0.020 |
Why?
|
| Thymus Gland | 1 | 2010 | 1267 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3920 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6756 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16689 | 0.010 |
Why?
|
| Risk Factors | 2 | 2023 | 72290 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2013 | 3494 | 0.010 |
Why?
|
| Wound Healing | 1 | 2014 | 2785 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2022 | 25625 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 13033 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3690 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2021 | 53288 | 0.010 |
Why?
|
| Middle Aged | 2 | 2021 | 213383 | 0.010 |
Why?
|
| Adult | 1 | 2010 | 214055 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 19905 | 0.010 |
Why?
|
| Algorithms | 1 | 2013 | 13881 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 163280 | 0.000 |
Why?
|